C07D 223/20
Dibenz [b, e] azepines
Official title: Dibenz [b, e] azepines; Hydrogenated dibenz [b, e] azepines
C07D223/20 (Dibenz [b, e] azepines) appears on 73 US grants and 36 published applications in this corpus.
Search patents in C07D- Granted patents
- 73
- Published applications
- 36
- Assignees
- 51
- Inventors
- 227
- Latest grant
- 12 Oct 2021
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 3 | 0 |
| 1977 | 3 | 0 |
| 1978 | 1 | 0 |
| 1979 | 0 | 0 |
| 1980 | 1 | 0 |
| 1981 | 1 | 0 |
| 1982 | 3 | 0 |
| 1983 | 3 | 0 |
| 1984 | 4 | 0 |
| 1985 | 1 | 0 |
| 1986 | 1 | 0 |
| 1987 | 0 | 0 |
| 1988 | 0 | 0 |
| 1989 | 1 | 0 |
| 1990 | 0 | 0 |
| 1991 | 0 | 0 |
| 1992 | 0 | 0 |
| 1993 | 1 | 0 |
| 1994 | 2 | 0 |
| 1995 | 3 | 0 |
| 1996 | 4 | 0 |
| 1997 | 3 | 0 |
| 1998 | 9 | 0 |
| 1999 | 1 | 0 |
| 2000 | 2 | 0 |
| 2001 | 3 | 1 |
| 2002 | 0 | 1 |
| 2003 | 1 | 3 |
| 2004 | 1 | 2 |
| 2005 | 1 | 4 |
| 2006 | 3 | 3 |
| 2007 | 4 | 2 |
| 2008 | 1 | 3 |
| 2009 | 1 | 1 |
| 2010 | 0 | 1 |
| 2011 | 0 | 1 |
| 2012 | 0 | 0 |
| 2013 | 2 | 0 |
| 2014 | 0 | 1 |
| 2015 | 1 | 0 |
| 2016 | 0 | 2 |
| 2017 | 1 | 2 |
| 2018 | 0 | 2 |
| 2019 | 3 | 2 |
| 2020 | 1 | 0 |
| 2021 | 3 | 1 |
| 2022 | 0 | 1 |
| 2023 | 0 | 1 |
| 2024 | 0 | 0 |
| 2025 | 0 | 0 |
| 2026 | 0 | 2 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Neuropeptide S receptor (NPSR) agonists12 Oct 2021US 11,142,546 B2Research Triangle Institute
- Piperazine substituted azapine derivatives and uses thereof29 Jun 2021US 11,046,651 B2Alairion, Inc.
- Hepatitis B core protein allosteric modulators16 Mar 2021US 10,947,224 B2Assembly Biosciences, Inc.
- Dibenzo azepine compounds and their use in the treatment of otic diseases and disorders15 Dec 2020US 10,865,188 B2Pipeline Therapeutics, Inc.
- Derivatives of 7-fluoro-8-chloro-5H-dibenzo [B,E,] [1,4] diazepine and use thereof27 Aug 2019US 10,391,101 B2Valentek LLC
- Novel compounds with mtorc2-inhibitory activity and uses thereof10 Sep 2026US 2026/0265267 A1Aliad Biopharma
- Small molecule inhibitors of the ribosome biogenesis factor NVL29 Apr 2026US 2026/0097047 A1Board of Regents, The University of Texas System
- Hepatitis b core protein allosteric modulators19 Jan 2023US 2023/0019129 A1Assembly Biosciences, Inc.
- Solidification or crystallisation method12 May 2022US 2022/0143186 A1
- Piperazine substituted azapine derivatives and uses thereof22 Apr 2021US 2021/0114989 A1Alairion, Inc.
Most cited
By later US patents
- Tricyclic benzazepine vasopressin antagonists50US 5,512,563 AAmerican Cyanamid Company · 1996
- Diaminopropionic acid derivatives50US 6,331,640 B1Hoffmann-La Roche Inc. · 2001
- Tricyclic benzazepine vasopressin antagonists46US 5,849,735 AAmerican Cyanamid Company · 1998
- Diaminopropionic acid derivatives45US 6,803,384 B2Hoffmann-La Roche Inc. · 2004
- Benzamide derivatives and pharmaceutical composition comprising the same44US 5,521,170 AFujisawa Pharmaceutical Co., Ltd. · 1996